This will take effect October 1, 2012
Overview and Clinical Utility:
Effective October 1, 2012, Vitamin D 25 Hydroxy will be performed on the Diasorin Liaison XL using chemiluminescent immunoassay. Vitamin D testing is used in the assessment of vitamin D sufficiency. Assay results should be used in conjunction with other clinical or laboratory data to assist the clinician in making individual patient management decisions.
Click Here to read more.